1. Home
  2. NOTE vs IMUX Comparison

NOTE vs IMUX Comparison

Compare NOTE & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTE
  • IMUX
  • Stock Information
  • Founded
  • NOTE 2013
  • IMUX 2016
  • Country
  • NOTE United States
  • IMUX United States
  • Employees
  • NOTE N/A
  • IMUX N/A
  • Industry
  • NOTE EDP Services
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NOTE Technology
  • IMUX Health Care
  • Exchange
  • NOTE Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • NOTE 97.9M
  • IMUX 107.3M
  • IPO Year
  • NOTE N/A
  • IMUX N/A
  • Fundamental
  • Price
  • NOTE $0.64
  • IMUX $0.73
  • Analyst Decision
  • NOTE Strong Buy
  • IMUX Strong Buy
  • Analyst Count
  • NOTE 6
  • IMUX 6
  • Target Price
  • NOTE $2.63
  • IMUX $11.60
  • AVG Volume (30 Days)
  • NOTE 1.4M
  • IMUX 1.4M
  • Earning Date
  • NOTE 05-12-2025
  • IMUX 05-15-2025
  • Dividend Yield
  • NOTE N/A
  • IMUX N/A
  • EPS Growth
  • NOTE N/A
  • IMUX N/A
  • EPS
  • NOTE N/A
  • IMUX N/A
  • Revenue
  • NOTE $115,665,000.00
  • IMUX N/A
  • Revenue This Year
  • NOTE N/A
  • IMUX N/A
  • Revenue Next Year
  • NOTE $41.14
  • IMUX N/A
  • P/E Ratio
  • NOTE N/A
  • IMUX N/A
  • Revenue Growth
  • NOTE N/A
  • IMUX N/A
  • 52 Week Low
  • NOTE $0.56
  • IMUX $0.56
  • 52 Week High
  • NOTE $2.07
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • NOTE 46.83
  • IMUX 34.34
  • Support Level
  • NOTE $0.59
  • IMUX $0.56
  • Resistance Level
  • NOTE $0.67
  • IMUX $0.95
  • Average True Range (ATR)
  • NOTE 0.05
  • IMUX 0.07
  • MACD
  • NOTE 0.00
  • IMUX -0.03
  • Stochastic Oscillator
  • NOTE 42.62
  • IMUX 36.91

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: